| Code | Description | Claims | Beneficiaries | Total Paid |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
174,948 |
123,725 |
$575K |
| 80053 |
Comprehensive metabolic panel |
99,986 |
80,266 |
$465K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
69,052 |
48,189 |
$239K |
| 84443 |
Thyroid stimulating hormone (TSH) |
29,609 |
27,833 |
$230K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13,503 |
12,909 |
$225K |
| 80061 |
Lipid panel |
28,856 |
27,770 |
$188K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
113,596 |
64,566 |
$169K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
30,943 |
29,398 |
$163K |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
105,058 |
59,558 |
$92K |
| 84134 |
|
11,549 |
10,377 |
$89K |
| 80164 |
|
13,975 |
12,497 |
$89K |
| 36415 |
Collection of venous blood by venipuncture |
56,737 |
32,505 |
$62K |
| 83735 |
|
22,932 |
16,040 |
$58K |
| 83880 |
|
2,604 |
2,255 |
$55K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12,443 |
11,392 |
$48K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,012 |
362 |
$47K |
| 80177 |
|
5,464 |
4,929 |
$42K |
| 80202 |
|
7,216 |
2,491 |
$41K |
| 87186 |
|
9,372 |
5,881 |
$36K |
| 84439 |
|
8,083 |
7,609 |
$35K |
| 82140 |
|
3,973 |
3,299 |
$32K |
| 81001 |
|
25,496 |
23,112 |
$29K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
646 |
186 |
$29K |
| 82728 |
|
4,359 |
4,039 |
$28K |
| 87493 |
|
1,405 |
1,277 |
$26K |
| 80076 |
|
7,890 |
7,314 |
$25K |
| 87077 |
|
6,476 |
4,038 |
$23K |
| 82607 |
|
5,060 |
4,794 |
$23K |
| 82746 |
|
3,553 |
3,412 |
$22K |
| 85610 |
|
13,175 |
5,461 |
$21K |
| 80069 |
|
11,409 |
7,725 |
$21K |
| 83540 |
|
6,219 |
5,861 |
$21K |
| 86140 |
|
9,048 |
6,028 |
$19K |
| 83550 |
|
3,877 |
3,676 |
$17K |
| 87070 |
|
4,191 |
3,707 |
$16K |
| 84145 |
|
1,753 |
1,406 |
$16K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
45,067 |
31,867 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,018 |
530 |
$14K |
| 80185 |
|
2,140 |
1,572 |
$14K |
| 83970 |
|
754 |
714 |
$13K |
| 86480 |
|
327 |
311 |
$13K |
| 84100 |
|
5,393 |
3,827 |
$12K |
| 80159 |
|
1,288 |
889 |
$12K |
| 80050 |
General health panel |
503 |
496 |
$12K |
| 87631 |
|
208 |
205 |
$11K |
| 80178 |
|
2,718 |
2,385 |
$10K |
| 85652 |
|
9,718 |
6,614 |
$10K |
| 85027 |
|
3,467 |
3,079 |
$9K |
| 87040 |
|
1,907 |
958 |
$8K |
| 82248 |
|
2,538 |
2,235 |
$8K |
| 82274 |
|
1,036 |
786 |
$8K |
| 82805 |
|
459 |
372 |
$8K |
| 82565 |
|
2,728 |
1,950 |
$7K |
| 84481 |
|
812 |
779 |
$6K |
| 84436 |
|
1,423 |
1,381 |
$5K |
| 84466 |
|
860 |
793 |
$5K |
| 82550 |
|
1,429 |
1,085 |
$4K |
| 82040 |
|
1,554 |
1,447 |
$4K |
| 85730 |
|
1,201 |
1,024 |
$4K |
| 85018 |
|
4,574 |
2,159 |
$4K |
| 84550 |
|
2,040 |
1,926 |
$4K |
| 84460 |
|
1,201 |
1,015 |
$4K |
| 84132 |
|
1,896 |
1,463 |
$3K |
| 85014 |
|
3,838 |
1,774 |
$3K |
| 84520 |
|
1,508 |
992 |
$3K |
| 80162 |
|
574 |
516 |
$3K |
| 83690 |
|
665 |
636 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
182 |
178 |
$2K |
| 87088 |
|
597 |
502 |
$2K |
| 84153 |
|
261 |
256 |
$2K |
| R0070 |
Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen |
15 |
15 |
$2K |
| 80074 |
|
76 |
76 |
$2K |
| 84450 |
|
642 |
541 |
$2K |
| 85004 |
|
520 |
272 |
$2K |
| 82150 |
|
409 |
398 |
$2K |
| 82570 |
|
776 |
670 |
$2K |
| 82378 |
|
198 |
169 |
$2K |
| 82043 |
|
620 |
561 |
$2K |
| 84480 |
|
263 |
250 |
$2K |
| 82652 |
|
72 |
72 |
$2K |
| 80156 |
|
279 |
267 |
$1K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
405 |
398 |
$1K |
| 86592 |
|
503 |
487 |
$1K |
| R0075 |
Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, more than one patient seen |
25 |
25 |
$1K |
| 80184 |
|
241 |
206 |
$1K |
| 86703 |
|
86 |
81 |
$939.86 |
| 83605 |
|
298 |
256 |
$889.63 |
| 86803 |
|
106 |
99 |
$865.19 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
19 |
18 |
$853.73 |
| 84295 |
|
258 |
169 |
$798.89 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
51 |
50 |
$680.60 |
| 87045 |
|
161 |
153 |
$638.13 |
| Q0092 |
Set-up portable x-ray equipment |
50 |
48 |
$615.78 |
| 87340 |
|
72 |
71 |
$605.58 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
126 |
73 |
$597.93 |
| 84075 |
|
175 |
166 |
$563.44 |
| 86706 |
|
68 |
68 |
$562.61 |
| 86704 |
|
54 |
54 |
$520.72 |
| 85379 |
|
139 |
119 |
$493.91 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
25 |
25 |
$438.72 |
| 84479 |
|
92 |
91 |
$358.15 |
| 85045 |
|
204 |
192 |
$357.53 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
13 |
12 |
$332.35 |
| 82247 |
|
72 |
53 |
$318.57 |
| 71045 |
Radiologic examination, chest; single view |
72 |
59 |
$282.25 |
| 80051 |
|
42 |
26 |
$280.41 |
| 83615 |
|
145 |
136 |
$272.06 |
| 87324 |
|
42 |
41 |
$210.97 |
| 84146 |
|
45 |
42 |
$199.39 |
| 82310 |
|
54 |
50 |
$191.57 |
| 80165 |
|
49 |
46 |
$169.94 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$157.24 |
| 80173 |
|
15 |
14 |
$136.39 |
| 84165 |
|
38 |
37 |
$123.65 |
| 84156 |
|
88 |
85 |
$115.81 |
| 82947 |
|
52 |
51 |
$108.95 |
| 87101 |
|
16 |
16 |
$104.96 |
| 83519 |
|
22 |
20 |
$99.87 |
| 87220 |
|
49 |
46 |
$91.13 |
| 85049 |
|
33 |
32 |
$76.41 |
| 87205 |
|
50 |
41 |
$72.75 |
| 80299 |
|
16 |
12 |
$56.06 |
| 83516 |
|
15 |
14 |
$32.72 |
| 84155 |
|
12 |
12 |
$22.56 |
| 99199 |
Unlisted special service, procedure or report |
50 |
44 |
$0.00 |